| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 110,886 | 122,443 | 118,169 | 164,035 | | Cost of Revenue | 82,080 | 86,321 | 82,892 | 110,786 | | | Gross Profit | 28,806 | 36,122 | 35,277 | 53,249 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 27,792 | 29,911 | 28,168 | 29,981 | | Non Recurring |
-
|
-
|
-
| 1,351 | | Others | 3,634 | 3,604 | 3,583 | 3,767 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,620) | 2,607 | 3,526 | 18,150 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (1) | 1 |
-
| | Earnings Before Interest And Taxes | (3,096) | 2,606 | 3,527 | 18,150 | | Interest Expense | (319) | 141 | 178 | 299 | | Income Before Tax | (2,777) | 2,465 | 3,349 | 17,851 | | Income Tax Expense | (1,135) | 956 | 1,291 | 6,642 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,642) | 1,509 | 2,058 | 11,209 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,642) | 1,509 | 2,058 | 11,209 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,642) | $1,509 | $2,058 | $11,209 |
|
1.52% Nasdaq 
Income Statement
